Literature DB >> 8220904

Cerebral blood flow and cerebrovascular reactivity after inhibition of nitric oxide synthesis in conscious goats.

N Fernández1, J L García, A L García-Villalón, L Monge, B Gómez, G Diéguez.   

Abstract

1. The role of nitric oxide in the cerebral circulation under basal conditions and after vasodilator stimulation was studied in instrumented, conscious goats, by examining the action of inhibiting endogenous nitric oxide production with NG-nitro-L-arginine methyl ester (L-NAME). 2. In 6 unanaesthetized goats, blood flow to one brain hemisphere (electromagnetically measured), systemic arterial blood pressure and heart rate were continuously recorded. L-NAME (35 mg kg-1 by i.v. bolus) decreased resting cerebral blood flow by 43 +/- 3%, increased mean arterial pressure by 21 +/- 2%, and decreased heart rate by 41 +/- 2%; cerebrovascular resistance increased by 114 +/- 13% (P < 0.01); the immediate addition of i.v. infusion of L-NAME (0.15-0.20 mg kg-1 during 60-80 min) did not significantly modify these effects. Cerebral blood flow recovered at 72 h, arterial pressure and cerebrovascular resistance at 48 h, and heart rate at 6 days after L-NAME treatment. 3. A second treatment with L-NAME scheduled as above reproduced the immediate haemodynamic effects of the first treatment, which (except bradycardia) reversed with L-arginine (200-300 mg kg-1 by i.v. bolus). 4. Acetylcholine (0.01-0.3 micrograms), sodium nitroprusside (3-100 micrograms) and diazoxide (0.3-9 mg), injected into the cerebral circulation of 5 conscious goats, produced dose-dependent increases in cerebral blood flow, and decreases in cerebrovascular resistance; sodium nitroprusside (30 and 100 micrograms) also caused hypotension and tachycardia. 5. The reduction in cerebrovascular resistance from resting levels (in absolute values) to lower doses,but not to the highest dose, of acetylcholine was diminished, to sodium nitroprusside was increased, and to diazoxide was unaffected after L-NAME, compared to control conditions. The effects on cerebrovascular resistance to acetycholine normalized within 24 h and to sodium nitroprusside within 48 h after L-NAME treatment.6. This study provides information about the evolution of the changes in cerebral blood flow and cerebrovascular reactivity after inhibition of endogenous nitric oxide in conscious animals. The results suggest: (a) endogenous nitric oxide is involved in regulation of the cerebral circulation by producing a resting vasodilator tone, (b) the cerebral vasodilatation to acetylcholine is mediated, at least in part, by nitric oxide release, and (c) inhibition of nitric oxide production induces supersensitivity of cerebral vasculature to nitrovasodilators.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8220904      PMCID: PMC2175992          DOI: 10.1111/j.1476-5381.1993.tb13828.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  36 in total

1.  Cerebral hemodynamics following internal maxillary artery ligation in the goat.

Authors:  D J Miletich; A D Ivankovic; R F Albrecht; E T Toyooka
Journal:  J Appl Physiol       Date:  1975-05       Impact factor: 3.531

2.  Does nitric oxide mediate the increases in cerebral blood flow elicited by hypercapnia?

Authors:  C Iadecola
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

3.  Development and evaluation of an experimental model for the study of the cerebral circulation in the unanesthetized goat.

Authors:  C Reimann; S Lluch; G Glick
Journal:  Stroke       Date:  1972 May-Jun       Impact factor: 7.914

4.  Diminished muscarinic receptor-mediated cerebral blood flow response in streptozotocin-treated rats.

Authors:  D A Pelligrino; D J Miletich; R F Albrecht
Journal:  Am J Physiol       Date:  1992-04

5.  The influence of atropine and atenolol on the cardiac haemodynamic effects of NG-nitro-L-arginine methyl ester in conscious, Long Evans rats.

Authors:  R E Widdop; S M Gardiner; P A Kemp; T Bennett
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

6.  Effects of NG-nitro-L-arginine and L-arginine on regional cerebral blood flow in the cat.

Authors:  A G Kovách; C Szabó; Z Benyó; C Csáki; J H Greenberg; M Reivich
Journal:  J Physiol       Date:  1992-04       Impact factor: 5.182

7.  Effects of NG-nitro-L-arginine methyl ester on vasodilator responses to acetylcholine, 5'-N-ethylcarboxamidoadenosine or salbutamol in conscious rats.

Authors:  S M Gardiner; P A Kemp; T Bennett
Journal:  Br J Pharmacol       Date:  1991-07       Impact factor: 8.739

8.  Does basal production of nitric oxide contribute to regulation of brain-fluid balance?

Authors:  F M Faraci; D D Heistad
Journal:  Am J Physiol       Date:  1992-02

9.  Baroreceptor reflexes and vascular reactivity during inhibition of nitric oxide synthesis in conscious rabbits.

Authors:  Z Y Du; G J Dusting; O L Woodman
Journal:  Eur J Pharmacol       Date:  1992-04-07       Impact factor: 4.432

10.  Effects of nitric oxide synthesis inhibition on the goat coronary circulation under basal conditions and after vasodilator stimulation.

Authors:  J L García; N Fernández; A L García-Villalón; L Monge; B Gómez; G Diéguez
Journal:  Br J Pharmacol       Date:  1992-07       Impact factor: 8.739

View more
  3 in total

1.  Cerebral vasoconstriction produced by vasopressin in conscious goats: role of vasopressin V(1) and V(2) receptors and nitric oxide.

Authors:  N Fernández; M A Martínez; A L García-Villalón; L Monge; G Diéguez
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

2.  The role of nitric oxide synthesis in cardiovascular responses to acute hypoxia in the late gestation sheep fetus.

Authors:  L R Green; L Bennet; M A Hanson
Journal:  J Physiol       Date:  1996-11-15       Impact factor: 5.182

3.  Regional differences in the arterial response to vasopressin: role of endothelial nitric oxide.

Authors:  A L García-Villalón; J L Garcia; N Fernández; L Monge; B Gómez; G Diéguez
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.